GMED gains musculoskeletal share on strong spine and trauma growth, while product innovation and a d

Globus Medical, Intuitive Surgical and Thermo Fisher Scientific have been highlighted in this Indust

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

GenAI offers growth opportunities for GMED, ISRG and TMO, but evolving regulations and industry risk

RBC Capital analyst Kendall Au maintains Globus Medical (NYSE:GMED) with a Outperform and lowers

Investors interested in Medical - Instruments stocks are likely familiar with Globus Medical (GMED)

Strong performance across the healthtech sector over the past two quarters has sparked renewed marke

Globus Medical (GMED) might move higher on growing optimism about its earnings prospects, which is r

Robotics is poised for robust long-term growth. Consider NVDA, TER, ZBRA and GMED for potential mark

Investors with an interest in Medical - Instruments stocks have likely encountered both Globus Medic

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

RCMT, HCSG, BLMN, AGX and GMED have been added to the Zacks Rank #1 (Strong Buy) List on September 1

GenAI offers growth potential for VCYT, GMED and UFPT, but regulatory and technology risks are likel

Globus Medical, NetApp and Assurant stand out for sustainable sales growth, strong cash flow and fav

BP, CRD.B, HCSG, TILE and GMED have been added to the Zacks Rank #1 (Strong Buy) List on September 9

Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, today announced that

Excelsius3D™ – Intelligent 3-in-1 Imaging System Expands Excelsius™ Ecosystem in the European Union

Globus Medical (GMED) could produce exceptional returns because of its solid growth attributes.

The mean of analysts' price targets for Globus Medical (GMED) points to a 25% upside in the stock. W

Investors looking for stocks in the Medical - Instruments sector might want to consider either Globu

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

American Capital Management Inc. acquired a new stake in shares of Globus Medical, Inc. (NYSE: GMED)

Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, today announced the

Wells Fargo analyst Larry Biegelsen maintains Globus Medical (NYSE:GMED) with a Overweight and lo

Globus Medical (NYSE:GMED) raises FY2026 Adj EPS guidance from $4.70-$4.80 to $4.95-$5.05 vs $4.74 a

Globus Medical (NYSE:GMED) reported quarterly earnings of $1.34 per share which beat the analyst con

Truist Securities analyst Richard Newitter maintains Globus Medical (NYSE:GMED) with a Buy and lo

RBC Capital analyst Shagun Singh maintains Globus Medical (NYSE:GMED) with a Outperform and lower

BMO Capital initiates coverage on Globus Medical (NYSE:GMED) with a Outperform rating and announce

Stifel analyst Tom Stephan maintains Globus Medical (NYSE:GMED) with a Hold and lowers the price

Tech and semis lead the S&P 500 and Nasdaq higher into quarter-end

Top Wall Street analysts changed their outlook on top names. See all rating changes on our analyst r

Piper Sandler analyst Matt O'Brien maintains Globus Medical (NYSE:GMED) with a Overweight and

Cramer says Rocket Companies is a "play" on the idea that new Fed Chair Kevin Warsh will cut

RBC Capital analyst Shagun Singh maintains Globus Medical (NYSE:GMED) with a Outperform and raise

Wells Fargo analyst Larry Biegelsen maintains Globus Medical (NYSE:GMED) with a Overweight and lo

Needham analyst David Saxon maintains Globus Medical (NYSE:GMED) with a Buy and raises the price

Globus Medical (NYSE:GMED) raises FY2026 Adj EPS guidance from $4.40-$4.50 to $4.70-$4.80 vs $4.47 a

Globus Medical (NYSE:GMED) reported quarterly earnings of $1.12 per share which beat the analyst con

Wells Fargo analyst Vik Chopra maintains Globus Medical (NYSE:GMED) with a Overweight and raises

Barclays analyst Matt Miksic maintains Globus Medical (NYSE:GMED) with a Overweight and raises th

Needham analyst David Saxon maintains Globus Medical (NYSE:GMED) with a Buy and raises the price

Needham analyst David Saxon upgrades Globus Medical (NYSE:GMED) from Hold to Buy and announces $1

Canaccord Genuity analyst Caitlin Cronin maintains Globus Medical (NYSE:GMED) with a Buy and rais

Piper Sandler analyst Matt O'Brien reiterates Globus Medical (NYSE:GMED) with a Overweight an